{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:14:58Z","timestamp":1772270098397,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.hbpd.2023.11.007","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T17:03:46Z","timestamp":1700845426000},"page":"385-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of biliary protein spectrum in gallstone patients with obesity and those with normal body weight"],"prefix":"10.1016","volume":"23","author":[{"given":"Min-Zhi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Hua","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2023.11.007_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13017-020-00336-x","article-title":"2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis","volume":"15","author":"Pisano","year":"2020","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.hbpd.2022.01.001","article-title":"Simplified calculation of bile cholesterol saturation index","volume":"21","author":"Zhang","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0003","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jhep.2019.06.011","article-title":"Obeticholic acid may increase the risk of gallstone formation in susceptible patients","volume":"71","author":"Al-Dury","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.100289","article-title":"The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation","volume":"23","author":"Lu","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0005","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2017.01.001","article-title":"Activation of the hypoxia inducible factor 1\u03b1 subunit pathway in steatotic liver contributes to formation of cholesterol gallstones","volume":"152","author":"Asai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0006","doi-asserted-by":"crossref","first-page":"G855","DOI":"10.1152\/ajpgi.00316.2015","article-title":"Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis","volume":"310","author":"Tharp","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0007","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/genes11121438","article-title":"An update on the lithogenic mechanisms of cholecystokinin a receptor (CCKAR), an important gallstone gene for lith13","volume":"11","author":"Wang","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1477-2574.2012.00457.x","article-title":"Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population","volume":"14","author":"Xu","year":"2012","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0009","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2296-15-138","article-title":"The association of metabolic syndrome and its factors with gallstone disease","volume":"15","author":"Lin","year":"2014","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0010","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/hep.26563","article-title":"Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study","volume":"58","author":"Stender","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hbpd.2022.03.009","article-title":"Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease","volume":"21","author":"Huh","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/mol.119.115840","article-title":"Hepatic expression of niemann-Pick C1-like 1, a cholesterol reabsorber from bile, exacerbates Western diet-induced atherosclerosis in LDL receptor mutant mice","volume":"96","author":"Yamamoto","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116638","article-title":"Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats","volume":"232","author":"Duan","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0014","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.hbpd.2021.05.006","article-title":"Bioinformatics: a beacon of hope in identifying molecular target","volume":"20","author":"Wang","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12929-019-0599-5","article-title":"Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma","volume":"27","author":"Voigtl\u00e4nder","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317705764","article-title":"A comparative proteomic analysis of bile for biomarkers of cholangiocarcinoma","volume":"39","author":"Laohaviroj","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0017","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbadis.2017.09.012","article-title":"Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis","volume":"1864","author":"Rupp","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0018","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/cancers12061644","article-title":"Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: a machine-learning approach","volume":"12","author":"Urman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0019","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/ijms18061126","article-title":"The peroxisome-mitochondria connection: how and why?","volume":"18","author":"Fransen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.metabol.2018.03.016","article-title":"HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1\u03b1 promoter","volume":"85","author":"Xu","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0022","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0023","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nm.2332","article-title":"Brain PPAR-\u03b3 promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones","volume":"17","author":"Lu","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0024","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1499-3872(14)60009-6","article-title":"Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells","volume":"13","author":"Byun","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-020-01334-3","article-title":"The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models","volume":"19","author":"Fan","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0026","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/hq1101.098228","article-title":"Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression","volume":"21","author":"Post","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0027","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbalip.2019.05.014","article-title":"Hepatocyte peroxisome proliferator-activated receptor \u03b1 regulates bile acid synthesis and transport","volume":"1864","author":"Xie","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfx237","article-title":"Alteration of bile acid and cholesterol biosynthesis and transport by perfluorononanoic acid (PFNA) in mice","volume":"162","author":"Zhang","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0029","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/jgh.14265","article-title":"Association of circulating inflammation proteins and gallstone disease","volume":"33","author":"Liu","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.11.007_bib0030","article-title":"Landscape in the gallbladder mycobiome and bacteriome of patients undergoing cholelithiasis with chronic cholecystitis","volume":"14","author":"Hu","year":"2023","journal-title":"Front Microbiol"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223002205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223002205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T09:14:39Z","timestamp":1728897279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387223002205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1499387223002205"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.11.007","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of biliary protein spectrum in gallstone patients with obesity and those with normal body weight","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}